Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intradermal polydioxanone injection for atrophic acne scars
TCTR20250319002Phase 4Unknown
- Sponsor
- Ultra V
- Start
- Jan 2025
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in atrophic acne scar (2 arms), sponsored by Ultra V. Primary endpoint: Volume and size of atrophic acne scar at 3 months. Status: unknown.
02
Conditions
atrophic acne scar
Beyond the preview
Go deeper on TCTR20250319002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20250319002.